US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-21 17:19:47 Source：Culture Chronicles news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
- Amir Khan's £11.5m luxury wedding venue finally hosts its first marriage: Bride arrives on horse
- New Journey, New Achievements — An Overview of Achievements in China Women's Cause in the New Era
- ACWF Holds Meeting to Study CPC Plenum Guiding Principles
- Chinese State Councilor Meets Thai Princess Sirindhorn
- Nadal returns to Roland Garros to practice amid doubts over fitness and form
- Shen Meets Norov
- For a Shared Dream Exhibition Opens in Beijing
- ACWF Holds Conference to Study, Implement Spirit of 20th CPC National Congress
- Medics remove 150 MAGGOTS from a woman's mouth after dental procedure left her with rotting tissue
- China's Women Olympic Athletes Honored
- Ricky Stenhouse punching Kyle Busch could lead to suspension
- Shen Addresses Opening Ceremony of Third Eurasian Women's Forum
- ACWF Calls on Women to Follow Party's Leadership, Embark on New Journey
- Death toll rises to 10 following Taiwan's 7.3
- Elon Musk gets approval from FDA to implant his Neuralink brain chip into a second patient
- Shen Yueyue Stresses High
- State Councilor Stresses Stable Employment, Supporting Women's Entrepreneurship
- CPC Delegation Visits Trinidad and Tobago
- Medics remove 150 MAGGOTS from a woman's mouth after dental procedure left her with rotting tissue
- Huang Addresses Second Women Power Forum, Inaugural Ceremony of HKFW's Board (2021
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Culture Chronicles news portal sitemap